Case Studies

Medical Device Manufacturer Enables Rapid Scalability and Innovation with SAP S/4HANA Implementation CASE STUDY Who is Enable Injections? Enable Injections is a developer of on-body delivery devices designed to self-administer high-volume and high-viscosity therapeutics. Today, their disruptive technology, enFuse™, has the potential to allow patients to safely, conveniently and cost-effectively administer treatments outside of a clinical facility for cancer, Parkinson's, Crohn's, rheumatoid arthritis and more—helping to revolutionize the way patients receive their infusions. Establishing a Strong Foundation Enable Injections' groundbreaking technology holds the potential to completely revolutionize the way patients receive critical treatment—and the company knew it was time to bring its technology to market on a large scale. Over the next five years, Enable Injections' goal was to bring millions of units to market with their pharma partners. However, with this goal in sight, Enable Injections needed to address a key challenge: working through FDA approvals and bringing a combination of products to market is a complicated and lengthy process that involves a lot of money and a great number of people. But once approvals are granted, the new pace can shift quickly and, like accelerating into a turn, precision performance is needed to successfully maneuver it. To make the jump f rom small start-up to big business, Enable Injections Executive Vice President and Chief Financial Officer Tim Flaherty knew he needed an enterprise IT system that could support its growth. "We have pharmaceutical firms talking about Enable Injections Gained flexibility to scale with new partners Automated management of FDA requirements Realized full integration across entire business system 1-855-739-3227 | hello@navisite.com navisite.com We could see where our business was heading and knew we needed to be prepared for it, but we also wanted a practical approach that allowed us to easily expand when the time was right." Tim Flaherty Executive Vice President & Chief Financial Officer Enable Injections "

• Cover